Amino acid transporters, including LAT1, can activate mTOR signals and various cancer-related molecules (HIF1A, growth factors, and kinases) through regulation of amino acid metabolism and protein synthesis, leading to cancer stemness and metastatic invasiveness, as well as therapeutic resistance [31,32]. This evidence concerns the gene SLC38A7 and cancer.